Investing.com - Boston Scientific (NYSE:BSX) reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Boston Scientific announced earnings per share of $0.44 on revenue of $3.24B. Analysts polled by Investing.com anticipated EPS of $0.4239 on revenue of $3.21B.
Boston Scientific shares are up 14.52% from the beginning of the year, still down 20.08% from its 52 week high of $47.49 set on April 20. They are outperforming the S&P 500 which is down 17.73% from the start of the year.
Boston Scientific follows other major Healthcare sector earnings this month
Boston Scientific's report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar